OVERACTIVE BLADDER SYNDROME: IS A REQUEST FOR A DOSE INCREASE INDICATIVE OF MORE SEVERE SYMPTOMS? RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, RISFNG-DOSE STUDY OF SOLIFENACIN (SUNRISE) ArticleCardozo L., Avdoshin V., Wolski Z., Pavlik I., Sofras F.E., Toth Z., Vasco P.M., Drogendijk T., Wright D.M., Bolodeoku J.INTERNATIONAL UROGYNECOLOGY JOURNAL. Vol. 18. 2007.
PREDICTORS OF REGRESSION AND PERSISTENCE LEFT VENTRICULAR HYPERTROPHY DURING LONG TERM ANTIHYPERTENSIVE TREATMENT ArticleEfimova V., Bulkina O., Malaya I., Milto A.Journal of Hypertension. Vol. 25. 2007.